FDA permits marketing of artificial intelligence-based device to detect certain diabetes

FDA permits marketing of artificial intelligence-based device to detect certain diabetes

  • April 13, 2018
Table of Contents

FDA permits marketing of artificial intelligence-based device to detect certain diabetes

The U.S. Food and Drug Administration today permitted marketing of the first medical device to use artificial intelligence to detect greater than a mild level of the eye disease diabetic retinopathy in adults who have diabetes.

Source: fda.gov

Share :
comments powered by Disqus

Related Posts

Looking to Listen: Audio-Visual Speech Separation

Looking to Listen: Audio-Visual Speech Separation

People are remarkably good at focusing their attention on a particular person in a noisy environment, mentally “muting” all other voices and sounds. Known as the cocktail party effect, this capability comes natural to us humans. However, automatic speech separation — separating an audio signal into its individual speech sources — while a well-studied problem, remains a significant challenge for computers.

Read More
AI Cardiologist Aces Its First Medical Exam

AI Cardiologist Aces Its First Medical Exam

When both the AI and expert cardiologists were asked to classify the images, the AI achieved an accuracy of 92 percent. The humans got only 79 percent correct.

Read More